tiprankstipranks
Solid Biosciences upgraded to Outperform from Market Perform at Leerink
PremiumThe FlySolid Biosciences upgraded to Outperform from Market Perform at Leerink
28d ago
FDA’s Sarepta decision ‘positive’ for gene therapy, STATNews reports
PremiumThe Fly
FDA’s Sarepta decision ‘positive’ for gene therapy, STATNews reports
1M ago
Piper sees opportunity for Solid Biosciences after broad Elevidys approval
PremiumThe Fly
Piper sees opportunity for Solid Biosciences after broad Elevidys approval
1M ago
Solid Biosciences price target lowered to $10 from $12 at JPMorgan
PremiumThe FlySolid Biosciences price target lowered to $10 from $12 at JPMorgan
2M ago
Solid Biosciences price target lowered to $18 from $21 at Barclays
PremiumThe Fly
Solid Biosciences price target lowered to $18 from $21 at Barclays
2M ago
Solid Biosciences expects cash to fund strategic priorities into 2026
PremiumThe Fly
Solid Biosciences expects cash to fund strategic priorities into 2026
2M ago
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesSolid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4M ago
Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
PremiumPress Releases
Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
4M ago
Solid Biosciences receives Rae Pediatric Disease designation for SGT-003
PremiumThe Fly
Solid Biosciences receives Rae Pediatric Disease designation for SGT-003
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100